Inventor · disambiguated record
Nir Hacohen
Also filed as: HACOHEN NIR
29 granted patents·35 pending applications·231 citations·filing 1997–2025
96Inventor score
Files withBROAD INST INC27DANA FARBER CANCER INST INC10MASSACHUSETTS GEN HOSPITAL10HACOHEN NIR3MASSACHUSETTS INST TECHNOLOGY3
Top patents by PatentIndex Score
64 records- 0196US11939637B2Molecular biomarkers for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Mar 26, 2024·3 cites·12 claims
- 0296US10426824B1Compositions and methods of identifying tumor specific neoantigensMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Oct 1, 2019·19 cites·20 claims
- 0396US9115402B2Compositions and methods of identifying tumor specific neoantigensHACOHEN NIR·Filed 2011·Granted Aug 25, 2015·77 cites·46 claims
- 0495US10835585B2Shared neoantigensBROAD INST INC·Filed 2016·Granted Nov 17, 2020·26 cites·35 claims
- 0594US11597934B2Methods and compositions for reducing immunosuppression by tumor cellsDANA FARBER CANCER INST INC·Filed 2020·Granted Mar 7, 2023·3 cites·20 claims
- 0694US10975442B2Molecular biomarkers for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Apr 13, 2021·8 cites·12 claims
- 0793US8273357B2Antigen-carbohydrate conjugatesHACOHEN NIR·Filed 2005·Granted Sep 25, 2012·39 cites·49 claims
- 0891US11452768B2Combination therapy with neoantigen vaccineBROAD INST INC·Filed 2014·Granted Sep 27, 2022·7 cites·32 claims
- 0991US10876120B2Methods and compositions for reducing immunosupression by tumor cellsDANA FARBER CANCER INST INC·Filed 2018·Granted Dec 29, 2020·5 cites·9 claims
- 1090US10993997B2Methods for profiling the t cell repertoireBROAD INST INC·Filed 2015·Granted May 4, 2021·7 cites·41 claims
- 1189US7855074B2Artificial immune system: methods for making and useVAXDESIGN CORP·Filed 2005·Granted Dec 21, 2010·13 cites·46 claims
- 1288US9944931B2Methods and compositions for reducing immunosupression by tumor cellsDANA FARBER CANCER INST INC·Filed 2014·Granted Apr 17, 2018·11 cites·11 claims
- 1385US10962527B2Multi-stage, multiplexed target isolation and processing from heterogeneous populationsBROAD INST INC·Filed 2017·Granted Mar 30, 2021·3 cites·12 claims
- 1479US2023383298A1Methods and Compositions for Reducing Immunosupression by Tumor CellsDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 1577US12394502B2Method for predicting HLA-binding peptides using protein structural featuresMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Aug 19, 2025·1 cites·19 claims
- 1676US9625444B2Artificial immune system: methods of useSANOFI PASTEUR VAXDESIGN CORP·Filed 2014·Granted Apr 18, 2017·1 cites·23 claims
- 1775US11650211B2HLA-based methods and compositions and uses thereofNEON THERAPEUTICS INC·Filed 2019·Granted May 16, 2023·2 cites·23 claims
- 1871US2023384320A1Hla-based methods and compositions and uses thereofBIONTECH US INC·Filed 2023·Application pending·0 cites
- 1970US2023190896A1Combination therapy with neoantigen vaccineBROAD INST INC·Filed 2022·Application pending·0 cites
- 2069US2020069783A1Compositions and methods of identifying tumor specific neoantigensMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 2169US2020016251A1Compositions and Methods of Identifying Tumor Specific NeoantigensDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2268US2025011859A1Compositions and methods for end to end capture of messenger rnasBROAD INST INC·Filed 2024·Application pending·0 cites
- 2368US2025012808A1Parallel antibody engineering compositions and methodsBROAD INST INC·Filed 2024·Application pending·0 cites
- 2468US2019060432A1Compositions and methods of identifying tumor specific neoantigensMASSACHUSETTS GEN HOSPITAL·Filed 2018·Application pending·0 cites
- 2566US12435372B2Methods for profiling the T-cell-receptor repertoireBROAD INST INC·Filed 2021·Granted Oct 7, 2025·0 cites·24 claims
- 2666US2021220455A1Compositions and methods for personalized neoplasia vaccinesBROAD INST INC·Filed 2020·Application pending·0 cites
- 2765US12188925B2Multi-stage, multiplexed target isolation and processing from heterogeneous populationsBROAD INST INC·Filed 2021·Granted Jan 7, 2025·0 cites·11 claims
- 2865US2018055922A1Compositions and methods of identifying tumor specific neoantigensDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 2965US2025084479A1Methods and compositions for determining the antigen specificity of t cellsBROAD INST INC·Filed 2024·Application pending·0 cites
- 3064US9901631B2Method and cells for the production of viral vaccinesBROAD INST INC·Filed 2013·Granted Feb 27, 2018·1 cites·15 claims
- 3162US2020368337A1Shared neoantigensBROAD INST INC·Filed 2020·Application pending·0 cites
- 3261US12421557B2Methods for predicting outcomes and treating colorectal cancer using a cell atlasBROAD INST INC·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 3361US2024182948A1Methods and compositions for detection of tumor dnaBROAD INST INC·Filed 2022·Application pending·0 cites
- 3461US2024124924A1High-throughput assessment of exogenous polynucleotide- or polypeptide-mediated transcriptome perturbationsBROAD INST INC·Filed 2022·Application pending·0 cites
- 3561US2016331822A1Compositions and methods of identifying tumor specific neoantigensDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
- 3661US2022002400A1Methods of Treating Influenza A Virus InfectionsHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 3760US2023407397A1Methods for identifying drivers of immune responses using molecular expression signatures of immunomodulating agentsMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 3859US2025223583A1An enzymatic system for precise cell targetingBROAD INST INC·Filed 2025·Application pending·0 cites
- 3958US2016008447A1Compositions and methods of identifying tumor specific neoantigensDANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
- 4058US2023193356A1Single cell combinatorial indexing from amplified nucleic acidsBROAD INST INC·Filed 2021·Application pending·0 cites
- 4157US2024150711A1Personalized redirection and reprogramming of t cells for precise targeting of tumorsDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 4256US11766446B2Treatment of aging-associated conditions by DNA degradationMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Sep 26, 2023·0 cites·14 claims
- 4356US2024398865A1Tumor avatar vaccine compositions and uses thereofBROAD INST INC·Filed 2022·Application pending·0 cites
- 4454US2024271138A1Methods and compositions for modulating sting signaling and innate immune responsesBROAD INST INC·Filed 2022·Application pending·0 cites
- 4553US12419948B2Immunogenic compositions and use thereofBROAD INST INC·Filed 2021·Granted Sep 23, 2025·0 cites·29 claims
- 4653US11965892B2HLA-based methods and compositions and uses thereofBIONTECH US INC·Filed 2018·Granted Apr 23, 2024·0 cites·21 claims
- 4752US2016101170A1Compositions and methods for personalized neoplasia vaccinesBROAD INST INC·Filed 2015·Application pending·0 cites
- 4851US2018289709A1Methods of treating inflammationBROAD INST INC·Filed 2017·Application pending·0 cites
- 4950US2023235394A1Chimeric amplicon array sequencingHACOHEN NIR·Filed 2021·Application pending·0 cites
- 5049US12226479B2Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereofMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Feb 18, 2025·0 cites·5 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nir Hacohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →